{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027270",
    "licUnit": "1",
    "validDate": "2027-11-13 00:00:00.000",
    "issueDate": "2017-11-13 00:00:00.000",
    "oriIssueDate": "2017-11-13",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202727000",
    "prodNameC": "英可欣膜衣錠45毫克",
    "prodNameE": "Iclusig 45mg film-coated tablets",
    "indicationsName": [
        "本品是一種酪胺酸激酶抑制劑(tyrosine kinase inhibitors, TKI)，適用於治療： 1. 費城染色體陽性急性淋巴性白血病(Ph+ ALL) (1) 併用化學治療，用於新診斷的費城染色體陽性急性淋巴性白血病(Ph+ ALL)的成人病人。 (2) 作為單一療法，用於無法以其他激酶抑制劑治療的費城染色體陽性急性淋巴性白血病(Ph+ ALL)或T315I陽性之費城染色體陽性急性淋巴性白血病(Ph+ ALL)的成人病人。 2. 慢性骨髓性白血病(CML) (1) 對先前至少兩種酪胺酸激酶抑制劑有抗藥性或無法耐受之慢性期(CP)慢性骨髓性白血病(CML)的成人病人。 (2) 無法以其他酪胺酸激酶抑制劑治療的加速期(AP)或急性期(BP)慢性骨髓性白血病(CML)的成人病人。 (3) T315I陽性之慢性期、加速期或急性期慢性骨髓性白血病(CML)的成人病人。 使用限制：Iclusig不適用於且不推薦用於治療新診斷為CP-CML病人。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2~1000粒",
            "packageUnit": "HE"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "A",
    "mainCategory": "A",
    "drBaseId": "766EEB29-AA27-49E3-80DD-B61B597DF406",
    "subCategory": [
        "A01"
    ],
    "ingredientsDesc": [
        "Ponatinib free base"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1D 須執行風險管理計畫",
        "5F 免除銜接性試驗"
    ],
    "applicantName": "台灣大塚製藥股份有限公司",
    "applicantAddr": "台北市中山區復興北路378號11樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2022-11-13",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "FFE8A50A-5D9B-437E-AB18-0D99044108C4",
            "factoryCode": "1",
            "factoryName": "Takeda Ireland Limited, Bray (TIL)",
            "factoryAddr": "Bray Business Park, Kilruddery, Co. Wicklow A98 CD36 Ireland",
            "factoryCompanyAddr": "",
            "countryCode": "IE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIE0148000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "20677CC6-B552-4368-A658-9053DB333375",
            "factoryCode": "2",
            "factoryName": "台灣大塚製藥股份有限公司中壢工廠",
            "factoryAddr": "桃園市中壢區吉林路15號",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [
                {
                    "value": "1Z",
                    "name": "委託包裝廠(貼標)"
                }
            ],
            "processCodeStr": "1Z;委託包裝廠(貼標)",
            "factoryKind": "M",
            "factoryNo": "1403304200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013005320",
            "ingredientsName": "Ponatinib free base",
            "ingredientsDesc": "Ponatinib free base",
            "concentDesc": "Ponatinib free base(added as ponatinib HCl)",
            "concent": "45.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA05"
        }
    ],
    "licBaseId": "7CF07E55-C528-4BE0-9295-B2DAA060435C"
}